Maternal–Neonatal Bacterial Concordance and Antimicrobial Susceptibility at Regional Referral Hospital, Northern Tanzania: A Cross-Sectional Study

Every baby arrives in the world carrying a hidden inheritance that is just as vital as their physical traits. Before a child takes their first breath, their body is largely a blank slate, but within hours, it begins to be populated by a vast community of microscopic organisms. These tiny residents, which live on the skin and inside the gut, are not merely passengers; they act as the first teachers of the immune system, helping to train the body to fight off harmful invaders and manage metabolism. Scientists have long understood that the primary source of these initial settlers is the mother. During a natural birth, a baby passes through the birth canal, picking up a specific mix of bacteria from the mother's vaginal and intestinal tract. This transfer is a critical moment in human development, setting the stage for the child's future health. However, the process is fragile. When a baby is born via surgery, or when antibiotics are used during labor, this natural exchange can be disrupted, potentially allowing different, sometimes more dangerous, bacteria to take hold. Understanding exactly which bacteria move from mother to child, and how resistant they are to medicine, is essential for protecting newborns in regions where infection remains a leading cause of illness.

In northern Tanzania, researchers set out to map this invisible transfer at the Mawenzi Regional Referral Hospital in Moshi. They focused on 314 pairs of mothers and their newborns, collecting samples immediately after delivery to see what bacteria were present and how they matched up. The team took swabs from the mothers' vaginas and from the rectums of the babies, capturing the microbial landscape at the very moment of birth. They then grew these bacteria in a laboratory to identify the species and tested how well they survived against common antibiotics. The goal was to see if the bacteria found on the baby were the same ones the mother carried, and to determine if the way the baby was born or the medications the mother took influenced which bacteria won the race to colonize the newborn.

The results revealed a clear and strong connection between the mother and the child. Out of the hundreds of bacterial samples collected, the most common organism found in both mothers and babies was a type of rod-shaped bacteria called Escherichia coli, followed closely by a round bacterium known as Staphylococcus aureus. The study confirmed that these bacteria were not just appearing by chance; there was a statistically significant link showing that when a mother carried a specific type of bacteria, her baby was very likely to carry the same type. This vertical transmission was so consistent that the researchers could trace the direct line of microbial inheritance from the mother's body to the infant's gut. The data showed that Escherichia coli was the dominant player, making up more than a third of all the bacteria found, while Staphylococcus aureus accounted for about one-fifth of the total. Other common residents included Klebsiella pneumoniae, Pseudomonas, and Proteus.

However, the study also uncovered a concerning pattern regarding how these bacteria respond to medicine. The researchers tested the bacteria against a wide range of antibiotics, from older, widely used drugs to newer, more powerful ones. They found that the bacteria were highly resistant to the traditional first-line treatments that doctors often rely on. For instance, the majority of the Staphylococcus aureus bacteria were immune to amoxicillin, and a large portion of the Escherichia coli and Klebsiella strains could not be killed by ampicillin or co-trimoxazole. In contrast, newer antibiotics like piperacillin-tazobactam and amikacin remained effective against most of the bacteria. This suggests that while the bacteria are successfully passing from mother to child, they are also passing on their ability to survive common medicines, leaving fewer options for treating infections if they occur.

The way a baby is born played a major role in which bacteria they encountered. The study found that babies born through a natural vaginal delivery were more likely to be colonized by the beneficial bacteria typically found in the mother's body. In contrast, babies born via caesarean section were significantly more likely to carry bacteria associated with the hospital environment. The researchers calculated that a caesarean delivery nearly doubled the likelihood of a baby being colonized by these hospital-associated organisms. Similarly, when a mother had taken antibiotics before or during labor, her baby was more likely to be colonized by these resistant, hospital-linked bacteria. This indicates that medical interventions, while sometimes necessary, can alter the natural microbial transfer, potentially exposing the newborn to harder-to-treat germs.

The findings from this study highlight a dual challenge for healthcare in the region. On one hand, the strong link between maternal and neonatal bacteria confirms that the mother is the primary source of a baby's first microbial community. On the other hand, the high levels of resistance to common antibiotics mean that this transfer can also pass on dangerous traits. The researchers concluded that to protect newborns, hospitals need to strengthen their infection control measures and use antibiotics more carefully. By minimizing unnecessary caesarean sections and ensuring that antibiotics are only used when truly needed, medical teams can help preserve the natural, beneficial transfer of microbes while reducing the risk of exposing vulnerable infants to resistant pathogens. This work provides a clear picture of the microbial reality in a regional hospital, offering a foundation for better practices that could improve the health outcomes of mothers and their babies.